The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of topoisomerase II alpha (TOP2A) protein overexpression to predict response to anthracycline-based chemotherapy.
S. Chan
No relevant relationships to disclose
J. S. Reis-Filho
No relevant relationships to disclose
P. D. Dickinson
No relevant relationships to disclose
P. Moseley
No relevant relationships to disclose
A. R. Green
No relevant relationships to disclose
I. O. Ellis
No relevant relationships to disclose
T. M. A. Abdel-Fatah
No relevant relationships to disclose